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Background: Sheep caseous lymphadenitis (CLA), caused by Corynebacterium pseudotuberculosis (Cp), is associated
with direct economic losses and presents significant zoonotic potential. Despite the importance of the disease, a
satisfactory vaccine model has not been developed. Thus, this study aimed to investigate the association between
haptoglobin (Hp) and IgM levels and the clinical progression of CLA in primarily infected sheep and in sheep
immunized with Cp- secreted antigens adjuvanted with Quillaja saponaria saponins. These animals were kept with
CLA-positive sheep to simulate natural exposure that occurs in field conditions. During the experiment, the Hp and
IgM levels were monitored for 21 days, and the development of internal CLA lesions was investigated through
necropsies on day182 post-immunization.
Results: Primarily infected sheep in Group 2 (inoculated with 2x105 Cp virulent strain) had higher Hp values
between the first and ninth days post inoculation (PI) than sheep in Group 1 (control; P < 0.05). Immunized animals
in Group 3 had significantly higher Hp values between the third and seventh days PI, compared with the control
group (P < 0.01). Binary logistic regression (BLR) analysis of primarily infected sheep indicated an association
between Hp concentration and CLA clinical progression: animals with high Hp values had 99.9% less risk of having
CLA abscesses than animals with low Hp levels (Odds ratio = 0.001, P < 0.05). Both experimental groups had
significantly higher IgM titers than the control group around the ninth and eleventh days PI (P < 0.05). The BLR
analysis for immunized sheep indicated an association between IgM levels and clinical progression: sheep with
high IgM titers had 100.0% less risk of having CLA abscesses than animals with low IgM levels (Odds ratio = 0.000,
P < 0.05).
Conclusions: Resistance to C. pseudotuberculosis infection is supported by the early acute phase response, in which
up-regulation of Hp and IgM were predictive of a lower risk of CLA lesion development. Because the immunogen
used in this study induced a high production of both Hp and IgM, Q. saponaria saponin should be considered a
promising candidate in vaccine formulations against sheep CLA.
Keywords: Caseous lymphadenitis, Small ruminants, Quillaja saponaria, Acute phase response, Haptoglobin,
Immunoglobulin M* Correspondence: meyer.roberto@gmail.com
1Laboratório de Imunologia e Biologia Molecular, Departamento de
Biointeração, Instituto de Ciências da Saúde, Universidade Federal da Bahia,
Av. Reitor Miguel Calmon, S/N - Vale do Canela, Salvador, BA CEP 40140-100,
Brazil
Full list of author information is available at the end of the article
© 2013 Bastos et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Bastos et al. BMC Veterinary Research 2013, 9:254 Page 2 of 7
http://www.biomedcentral.com/1746-6148/9/254Background
Caseous lymphadenitis (CLA) is a chronic infectious
disease of sheep and goats caused by the gram-positive bac-
teria Corynebacterium pseudotuberculosis (Cp). In addition
to the direct economic losses that may occur due to leather
depreciation and weight gain delay [1,2], CLA presents
zoonotic potential. Published data strongly indicate that
human Cp infection represents an important and signifi-
cant zoonosis [3].
Despite the importance of the disease, a satisfactory
vaccine model for sheep and goats has not been devel-
oped. Current knowledge of the immunity induced by
Cp indicates that resistance to infection involves both
nonspecific and specific host responses. Antibodies help
protect against infection [4,5], but for full protection
vaccine models must stimulate cellular immunity, such
as the activation of CD8+ cells and IFN-γ production by
Th1 cells [6-9]. The role of the innate immune system in
Cp infection has recently been investigated. It was dem-
onstrated that serum concentrations of haptoglobin
(Hp), serum amyloid A and α1 acid glycoprotein were
increased in a CLA experimental model in sheep [10]. It
was also suggested that sheep that did not develop
clinical signs of CLA in field conditions, had significantly
higher Hp levels during the acute phase of the disease
than sheep that developed superficial abscesses. Al-
though the exact role of Hp in defending against infec-
tion by Cp was not identified, data suggested that innate
immune mechanisms contributed to the resolution of
infection or resistance to the development of CLA pyo-
granulomas [11].
Considering the hypothesis that full protection against
Cp would be achieved by Th1 T cell activation, Quillaja
saponaria-derived saponins can be considered as poten-
tial candidates in vaccine formulations [12]. These sapo-
nins have been used in the formulation of veterinary
vaccines, stimulating the Th1 response and the produc-
tion of specific cytolytic T lymphocytes [13]. The aim of
this study was to investigate the association between
haptoglobin and IgM levels and the clinical progression
of CLA (presence or absence of lesions) in primarily
infected sheep and in sheep immunized with a saponin-
adjuvanted immunogen.Methods
Bacterial strains and secreted antigen production
We used two Cp strains in this study. The T1 strain was
used to produce secreted antigens in a previously opti-
mized chemically defined medium (CDM) [14]. This
antigenic solution (CDM-secreted antigen) was used as
immunogen. A virulent strain of Cp named VD57 was
used in the experimental infection model, as previously
described [15].Animals and experimental inoculations
Fifteen one-year-old Santa Inês ewes were used in the
experiment. Santa Inês is a naturalized breed from
northeastern Brazil and the experimental animals all
came from the same flock. Animal selection was based
on several criteria, including body condition, helminth-
free state as defined by fecal egg count, normochromic
mucosa at visual inspection, normal rectal temperature
and absence of abscesses or enlarged lymph nodes on
palpation. No sheep had clinical signs of CLA and all
were seronegative on an indirect ELISA at the beginning
of the study.
We determined our sample size based on the experi-
mental design described previously to investigate the
acute phase protein response in an experimental model
of ovine caseous lymphadenitis [10]. Factors such as the
preliminary (pilot) nature of this study and the require-
ment of sacrificing all experimental animals to investi-
gate internal lesions in subclinically infected sheep also
motivated the use of a small sample size, according to
previously published guidelines [16]. Animals were
divided into three groups. Group 1 (n = 3) was inocu-
lated with sterile 0.9% saline solution on day zero and
kept in an individual pen separated from the flock.
Group 2 (n = 6), the experimental infection group, was
inoculated with 1 ml of saline containing 2 × 105 CFU of
the Cp virulent strain VD57 on day zero. Group 3 (n = 6)
was immunized with 1 ml of a solution containing 250 μg
of CDM-secreted antigens adjuvanted with 1.5 mg of
Quillaja saponaria saponin (Sigma-Aldrich) on day zero,
and received an immunization booster on day 56. The
adjuvant was prepared by dissolving the saponin at a
concentration of 150 mg/ml in sterile 0.9% saline solution
as a stock solution and filtering through a 0.22 μm
membrane. On the immunization days, the saponin stock
solution was added to the secreted antigen to a final con-
centration of 1.5 mg/ml [17], and the mixture was stirred
for 30 minutes before administration. All inoculations
were performed subcutaneously in the right flank. An
additional 12 CLA-positive sheep, presenting external
lesions and positive serology by ELISA, were kept with
Groups 2 and 3 from day zero (time of inoculation/
immunization) until day 182 (last day of observation) to
simulate natural exposure that occurs in field conditions.
These animals were kept on pasture during the day,
with free access to water, and returned to pens by the
end of each day to receive protein and mineral
supplementation.
This experiment was conducted under the authority of
Brazilian Law nº11.794, 8 October 2008 (statements on
the use of animals in research experiments), after
approval by the Secretariat of Animal Health of the
Ministry of Agriculture, Livestock and Food Supply.
Slaughter was conducted at a slaughterhouse supervised
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Sample collection and analysis
Blood samples were collected before inoculation/immu-
nization (day zero) and on days 1, 3, 5, 7, 9, 11, 14 and
21 post-inoculation (PI). On each occasion, one blood
aliquot was collected using vacuum tubes without
anticoagulant and allowed to clot at room temperature,
for serum collection. These samples were tested to
determine Hp and IgM levels.
Serum Hp concentration was estimated based on
hemoglobin-binding capacity in microtitration plates, as
previously described [11]. A standard curve was devel-
oped with standard Hp solutions (Sigma-Aldrich) diluted
from 1.050 to 0.008 g/L. Fifty μL of Hp standard or
serum sample was added to 50 μL of 0.9% saline solution
in each well. Next, 50 μL of sheep methemoglobin solu-
tion (30 mg/dL) was added and plates were incubated
for 10 minutes at 20°C. A blank (50 μL of 0.9% saline)
was run with each serum sample. Following incubation,
a guaiacol reagent (150 μL, pH 4.0) and 50 μL of H2O2
solution (0.02 mol/L) were added. After 5 minutes, ab-
sorbance at 490 nm was measured using a microplate
reader (Bio-Rad, Hercules, CA).
The indirect ELISA for detection of Cp-specific IgM
antibodies was performed as previously described [11].
ELISA microplates were sensitized with Cp supernatant
antigens (1:100 in carbonate-bicarbonate buffer, pH 9.6)
and incubated at 4°C for 16 hours. The blocking step
was made with 5% skim milk in PBS-T and incubated
for 2 hours at 37°C. Serum samples were pre-treated
(v/v 1:1) with Dynabeads Protein G (Invitrogen, Carlsbad,
CA), and 100 μL of these samples were added to the plates
in duplicate and incubated for 1 hour at 37°C. A rabbit
anti-ovine IgM polyclonal antibody conjugated with
horseradish peroxidase (Serotec, Raleigh, NC) was used as
detection antibody (1:20,000 in PBS-T) and incubated for
45 minutes at 37°C. Finally, the reaction was developed
with 100 μL/well of a solution containing H2O2 and
tetramethylbenzidine (Moss Inc., Pasadena, MD) for
15 minutes, and stopped with 4 N H2SO4. Results were
read in an ELISA plate reader (Bio-Rad) at 450 nm.
Although blood sampling focused on the acute phase
period (until the 21st day), clinical assessment continued
for six months, with all animals clinically examined
twice per month through the inspection of superficial
lymph nodes and routine blood sampling. External
abscesses found during the experiment period were
sampled through an incision with sterile surgical equip-
ment, followed by drainage of purulent material into
sterile flasks for bacteriological assays. After the 182-day
observation period, animals were necropsied at the Baby
Bode slaughterhouse (Feira de Santana, BA, Brazil), whichhas an official meat inspection system and performs
postmortem pathology inspections. All external and
internal lymph nodes, and tissue samples with lesions
suspected to be caused by Cp, were collected and
microbiologically assayed according to previously de-
scribed protocols [15,18].
Statistical analysis
Data were analyzed using IBM SPSS statistics, version
20.0. The distribution of Hp and IgM results was graph-
ically expressed through boxplots for each sampling
time. Results were compared between groups, and sig-
nificant differences (P < 0.05) were determined using the
nonparametric Mann–Whitney test. Based on the sum-
mary of records of external abscesses and post-mortem
examination (Table 1), a second series of graphics was
made using the animals’ data clustered by their CLA
clinical status: with CLA lesions (n = 5 in Group 2, n = 3
in Group 3) or without CLA lesions (n = 1 in Group 2,
n = 3 in Group 3). Binary logistic regression analysis was
used to examine the association between variables in
Groups 2 and 3 through the odds ratio (OR) calculation
[1,19]. The presence or absence of CLA lesions was
treated as the predicted dichotomous categorical variable
(outcome), while Hp and IgM levels during the acute
phase were considered as predictor continuous variables.
A model construct was done using a forward selection
of the variables. Adequacy of the final models was
assessed by the Hosmer and Lemeshow goodness-of-fit
test (P). P values < 0.05 were considered significant.
Complementary tables presenting the single haptoglobin
(g/l) and IgM (optical density at 490 nm) values for each
sheep during the acute phase period are provided as
additional files.
Results
The results of CLA lesion detection are presented in
Table 1. Group 1 (control) animals did not develop any
lesions. In Groups 2 and 3, there was a notable absence
of clinical signs of infection or inflammatory response
during the 182 days post-infection, except for one ani-
mal (#122) in Group 2, which developed an abscess at
the inoculation site. At slaughter, internal abscesses were
recorded in different sites and organs in five sheep in
Group 2 (animals # 122, 150, 156, 181 and 189) and in
three sheep in Group 3 (animals # 51, 61 and 141). The
number of lesions in each animal ranged from one to 18
in the lungs, liver and lymph nodes. All purulent content
of lesions had positive Cp isolation and identification. A
particular tropism for the lungs was detected in the
primarily infected animals (Group 2), but not in the
immunized sheep that presented CLA lesions. One
sheep from Group 2 (#602) was naturally resistant to Cp
infection and did not develop any pyogranulomas or
Table 1 Summary of external abscess records and post-mortem examination results
Group Animals Post mortem examination Final diagnosis
#1 - Control animals inoculated with
sterile 0.9% saline solution
# 001 No abscess ----
# 002 No abscess ----
# 003 No abscess ----
# 2 - Experimental infection with 2 × 105 CFU
C. pseudotuberculosis VD57 wild strain
# 122 Three abscesses in the inoculation site, one in the right cervical
lymph node and 17 abscesses in the lungs
Positive
# 150 Eight abscesses in the lungs Positive
# 156 One abscess in the lungs and one in the liver Positive
# 181 Two abscesses in the lungs Positive
# 189 One abscess in the lungs and one in the liver Positive
# 602 No abscess Negative
# 3 - Immunization with 250 μg CDM
antigen and 1.5 mg saponins
# 51 One abscess in the left parotid lymph node and one in the liver Positive
# 61 One abscess in the left cervical lymph node Positive
# 141 One abscess in the right parotid lymph node Positive
# 155 No abscess Negative
# 161 No abscess Negative
# 295 No abscess Negative
The final diagnosis was used to cluster animals by their disease status: with CLA lesions (positive) or without CLA lesions (negative).
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signs of CLA (animals # 155, 161 and 295).
The distribution of Hp values for each group during
the acute phase is shown in Figure 1. The primarily in-
fected sheep in Group 2 presented a typical acute phase
response curve with significantly higher (P < 0.05) Hp
values occurring between days 1 and 9 PI, in comparison
to Group 1 (control). The immunized animals in Group
3 showed a strong acute phase response, with Hp values
significantly higher (P < 0.05) than those of the control
group between days 1 and 11 PI. The highest Hp values
were detected between the third and seventh days PI in
Group 3, a notably significant difference in relation to
Group 1 (P < 0.01). Sheep in Group 3 had higher Hp
values than Group 2 animals on days 3, 5 and 7 PI (P <
0.05). Both groups’ Hp levels had returned to baseline by
day 14 PI.
Hp values clustered according to the presence or ab-
sence of CLA lesions are presented in Figure 2. The
highest measured Hp value (0.518 g/l), found in sheep
#602 in Group 2, was 3.1 times higher than the highest
mean Hp value (0.166 g/l) in other animals from the
same group. Sheep #602 was the animal naturally resist-
ant to Cp infection with no CLA lesion development.
(See Additional file 1 for single Hp values.) Binary logis-
tic regression analysis indicated a significant association
between high Hp values and the absence of CLA lesions
(P < 0.05; OR = 0.001).
The distribution of IgM values for each group is pre-
sented in Figure 1. (See Additional file 2 for single IgMvalues.) Experimental infection with 2 × 105 CFU of Cp
virulent strain VD57 induced higher IgM responses in
Group 2 than immunization did in Group 3, but these
differences were not significant. Both experimental
groups had significantly higher IgM values on days 9
and 11 PI compared with the control group (P < 0.05).
These results suggest that the adaptive immune response
can first be measured on day 9 PI.
IgM data clustered according to the presence or
absence of CLA lesions are presented in Figure 2. No
association with outcomes was detected in Group 2. All
sheep experimentally infected with 2 × 105 CFU Cp viru-
lent strain had elevated IgM levels during the acute
phase period. However, in Group 3, only those animals
that did not develop CLA abscesses had high IgM titers
between days 9 and 21 PI. Binary logistic regression
analysis indicated a significant association between high
IgM values and the absence of CLA lesions (P < 0.05;
OR = 0.000).Discussion
CLA is an important disease that affects sheep and
goats, with no satisfactory commercially available vac-
cine. In developing a reliable immunogen it is important
to consider the acute immune response, and IgM and
Hp are among the most important parameters during
this phase of the disease. Our aim in this study was to
observe the kinetics of these two acute phase markers in
the progression of CLA lesion development.
Figure 1 Distribution of haptoglobin and IgM values in sheep during CLA’s acute phase period. Values are expressed as boxplot graphics,
in which boxes represent the median value (line within box) and 25th and 75th percentiles (bottom and top of box); whiskers represent the 2.5th
and 97.5th percentiles; and dots represent outliers. Group 1, control group: animals inoculated with 0.09% saline solution; Group 2: inoculation
with 2 × 105 CFU of Corynebacterium pseudotuberculosis (Cp) VD57 wild strain; Group 3: immunization with 250 μg of CDM-secreted antigen plus
1.5 mg saponin. Significant differences (Sig.) between groups in Mann–Whitney test are presented at the top of each graphic with superscript
letters: a = Groups 1 and 2, b = Groups 1 and 3, c = Groups 2 and 3.
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developed CLA abscesses, probably as a result of natural
exposure to sheep with clinical CLA and draining
lesions. The observed tropism for the lungs was previ-
ously described in a study evaluating lesions in mice
inoculated with four equine Cp strains, which demon-
strated distinct tropism for the liver, spleen, lungs or
mesenteric lymph nodes [20]. In this study, because the
animals were naturally exposed to the pathogen, it is
very difficult to define the tropism of the circulating
strain in the flock.
The saponin-adjuvanted CDM-secreted antigen in-
duced a strong acute phase response between days 1 and
7 after immunogen inoculation. Haptoglobin is one of
the most sensitive acute phase markers of inflammatory
and infectious conditions in ruminants. This protein can
be used to assess the innate immune response to vaccin-
ation in sheep [21]. The existence of an Hp reaction in
ovine CLA has been previously reported, occurring
approximately 7 days PI [10]. However, our data show
that this acute phase response can be detected from day
1 PI, as shown in Figure 1.The OR obtained for Group 2 shows that the animal
with high Hp values during the acute phase response
had 99.9% less risk of developing CLA abscesses than
animals with low Hp levels. Although Group 3 had the
highest Hp levels, no association between Hp levels and
CLA lesion development could be detected. We were
unable to detect an association because inoculation with
the saponin-adjuvanted immunogen induced a strong
Hp reaction in all sheep. It has been suggested that a
high Hp level during the acute phase of Cp infection
represents a good prognosis for the clinical progression
of CLA in sheep [11]. One possible role of Hp against
infection is related to iron metabolism: high levels of
serum Hp might contribute to iron sequestration, making
the mineral less available for bacterial growth, as in the
case of Mycobacterium tuberculosis infection [22].
The OR calculated for Group 3 indicated that sheep
with high IgM titers during the acute phase period had
100.0% less risk of developing CLA abscesses than
animals with low IgM levels. Few studies regarding IgM
antibody levels during Cp infection have been published
to date, but our results agree with studies demonstrating
Figure 2 Haptoglobin and IgM values in Groups 2 and 3 according to CLA status. Values are expressed as mean ± standard error. Sheep
were clustered by the absence (green) and presence (black) of CLA lesions. Group 2: inoculation with 2 × 105 CFU of Cp VD57 wild strain; Group
3: immunization with 250 μg of CDM-secreted antigen plus 1.5 mg saponin. The association between variables and the clinical progression
(presence or absence of CLA lesions) was examined through binary logistic regression, and odds ratios (OR) are presented in grey boxes. Association
was considered significant if the P value was less than 0.05. The Hosmer and Lemeshow test P values were 0.221 (Group 2) and 0.803 (Group 3).
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response against Nocardia brasiliensis [23,24] and Myco-
bacterium tuberculosis [25].
Based on the Hp and IgM results of Group 3, it is
possible to infer that the saponin-adjuvanted CDM-
secreted antigen induced early defense mechanisms
during the acute phase period. However, it is not plaus-
ible to consider Hp and IgM as uniquely responsible for
protection against CLA. Although few vaccine models
using saponins as adjuvant have been tested in veterin-
ary medicine, prior studies have shown promising results
in protecting against murine visceral leishmaniasis [26],
bovine respiratory syncytial virus [27] and swine foot-
and-mouth disease virus [28]. These results indicate that
saponins may be a good choice for adjuvant in CLA
vaccine models.
Conclusions
Establishing the kinetics of Hp and IgM production
during the acute phase of infection in our two models
enabled us to characterize the association of these
variables with the clinical progression of CLA in sheep.
The results indirectly demonstrate that resistance to Cp
infection is supported by the early acute phase response,
with up-regulation of Hp and IgM predicting a lower
risk of developing CLA lesions. Because the immunogen
used in this study induced high production of both Hp
and IgM, Quillaja saponaria saponin should be considered
as a promising candidate in CLA vaccine formulations.Understanding the pathways initially activated by Cp anti-
gens is crucial to construct an effective vaccine model. We
highly recommend further studies on the modulation of
immunity by adjuvants during the acute phase of CLA
using a wider variety of immunological markers.Additional files
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haptoglobin value (g/l) for each sheep during the acute phase period.
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